Corporate ActionJul 23, 2026, 04:38 PM
Summit Therapeutics to Sell Up to $380M in Stock via ATM Offering
AI Summary
Summit Therapeutics Inc. has entered into a distribution agreement with J.P. Morgan Securities LLC to potentially sell up to $380,000,000 of its common stock. This "at the market" offering allows the company to raise capital from time to time, with J.P. Morgan acting as the sales agent and earning a commission of up to 3.0%. The company retains the flexibility to decide if and when to sell shares, with no obligation to do so.
Key Highlights
- Summit Therapeutics entered a distribution agreement with J.P. Morgan Securities LLC.
- Company may offer and sell up to $380,000,000 of common stock.
- Sales will be conducted as "at the market" offerings.
- J.P. Morgan Securities LLC will receive a commission of up to 3.0% of gross sales.
- The company is not obligated to sell any shares under the agreement.
Price Impact
More from SMMT